
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Contactin 2 CRISPR/Cas9 KO Plasmid (h) | sc-406301 | 20 µg | $397.00 |
CNTN2 encodes contactin 2 (TAG-1), a glycosylphosphatidylinositol (GPI)-anchored immunoglobulin superfamily cell-adhesion molecule enriched in the nervous system. Contactin 2 supports axon guidance, neurite outgrowth, and stabilization of neuron–glia interactions by organizing cell-surface recognition complexes and influencing cytoskeletal remodeling during neural circuit formation. It contributes to the assembly and maintenance of specialized membrane domains such as axon initial segments and juxtaparanodes through interactions with extracellular matrix and adhesion partners. Altered CNTN2 expression or function has been associated with neurodevelopmental and neuropsychiatric phenotypes, making it relevant for studies of synaptic connectivity and neuronal excitability.
Contactin 2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CNTN2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CNTN2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CNTN2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Contactin 2 protein expression.
This CRISPR knockout system enables efficient generation of CNTN2-deficient cell models for investigation of Contactin 2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.